GenNext Technologies Announces $2.5M Grant Award to Commercialize In-Cell Protein Footprinting Instrumentation GenNext will use this award to advance its intellectual property and expertise to develop a fully automated platform that will study drug-induced HOS structure changes within living cells, with its first system designed for in-vivo protein footprinting studies. HALF MOON BAY, Calif. – [...]
GenNext Technologies Announces its Second Key US Protein Footprinting Patent The United States Patent and Trademark Office (USPTO) has issued GenNext a Patent for Radical Dosimetry for the Analysis of Biopharmaceuticals and Biological Molecules. HALF MOON BAY, Calif. – December 9, 2021 – Life Science Newswire – GenNext Technologies, Inc., a growth-stage company providing instrumentation, software, and services, announced today that [...]
GenNext Technologies Announces NIH Grant Funding of Nearly $7M Leads to a Seminal Protein Footprinting Patent A new patent protects GenNext's intellectual property to advance the study of biopharmaceutical Higher Order Structure (HOS). HALF MOON BAY, Calif. – April 28, 2021 – Life Science Newswire – GenNext Technologies, Inc., a growth-stage company that provides instrumentation, software, and services to structural biology [...]